![Terrie Curran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Terrie Curran
Direktor/Vorstandsmitglied bei
ARCUTIS BIOTHERAPEUTICS, INC.
Vermögen: 4 Mio $ am 31.05.2026
Profil
Ms. Terrie Curran is an Independent Director at Arcutis Biotherapeutics, Inc. She is on the Board of Directors at Arcutis Biotherapeutics, Inc. and Roivant Sciences, Inc. Ms. Curran was previously employed as a President, Chief Executive Officer & Director by Phathom Pharmaceuticals, Inc., an Independent Director by Myovant Sciences Ltd., an Independent Director by H.
Lundbeck A/S, a President-Global Inflammation & Immunology by Celgene Corp., a SVP & GM-Global Women's Health by Merck & Co., Inc., and a General Manager by Schering-Plough Corp.
She also served on the board at BioNJ, Inc. She received her undergraduate degree from the University of Technology Sydney.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.03.2026 | 389’860 ( 0.49% ) | 4 Mio $ | 31.05.2026 | |
| 05.06.2026 | 17’748 ( 0.01% ) | 380 872 $ | 31.05.2026 |
Aktive Positionen von Terrie Curran
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 02.11.2020 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Terrie Curran
| Unternehmen | Position | Ende |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 31.03.2025 |
| MYOVANT SCIENCES LTD. | Direktor/Vorstandsmitglied | 10.03.2023 |
| CELGENE | Corporate Officer/Principal | 01.09.2019 |
| H. LUNDBECK A/S | Direktor/Vorstandsmitglied | 01.03.2017 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.04.2013 |
Ausbildung von Terrie Curran
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
University of Technology Sydney
 University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
